17191-43-4

Basic information

• Product Name: 1-{[(benzyloxy)carbonyl]amino}cyclohexanecarboxylic acid
• Synonyms: 1-{[(benzyloxy)carbonyl]amino}cyclohexanecarboxylic acid;1-(Cbz-amino)cyclohexanecarboxylic Acid;1-(Benzyloxycarbonylamino)cyclohexane-1-carboxylic acid;1-[[(Phenylmethoxy)carbonyl]amino]cyclohexanecarboxylic acid
• CAS NO: 17191-43-4
• Molecular Formula: C₁₅H₁₉NO₄
• Molecular Weight: 277.31566
• Product Categories: Amino Acids and Derivatives
• Mol File: 17191-43-4.mol
• Article Data: 18

Chemical Properties

• Boiling Point: 478.8°C at 760 mmHg
• Flash Point: 243.4°C
• Appearance: /
• Density: 1.23g/cm³
• Vapor Pressure: 5.62E-10mmHg at 25°C
• Refractive Index: 1.568
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-{[(benzyloxy)carbonyl]amino}cyclohexanecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-{[(benzyloxy)carbonyl]amino}cyclohexanecarboxylic acid(17191-43-4)
• EPA Substance Registry System: 1-{[(benzyloxy)carbonyl]amino}cyclohexanecarboxylic acid(17191-43-4)

Safety Data

• Hazardous Substances Data: 17191-43-4(Hazardous Substances Data)

Usage

General Description

1-{[(benzyloxy)carbonyl]amino}cyclohexanecarboxylic acid, also known as Boc-lysine, is a chemical compound that is commonly used in peptide synthesis. It is a derivative of the amino acid lysine, and is often employed as a protecting group for the amino group of lysine during peptide synthesis. Boc-lysine is a white crystalline powder that is soluble in organic solvents, and is commonly used in the pharmaceutical and biotechnology industries for the production of peptide-based drugs and bioactive compounds. It is an important component in the field of medicinal chemistry and drug development, and is valued for its ability to aid in the production of complex peptides and proteins.

InChI:InChI=1/C15H19NO4/c17-13(18)15(9-5-2-6-10-15)16-14(19)20-11-12-7-3-1-4-8-12/h1,3-4,7-8H,2,5-6,9-11H2,(H,16,19)(H,17,18)

Upstream product

• 2756-85-6 1-aminocyclohexane carboxylic acid 
• 501-53-1 benzyl chloroformate 
• 1552-92-7 ethyl cyclohexylideneacetate 
• 108-94-1 cyclohexanone 
• 932-89-8 2-cyclohexylidene ethanol 

Downstream Products

• 17191-50-3 1-(Benzyloxycarbonyl-amino)-cyclohexan-1-carbonsaeureamid 
• 144876-64-2 1-Benzyloxycarbonylamino-cyclohexanecarboxylic acid 2-trimethylsilanyl-ethyl ester 
• 455253-68-6 Acetic acid (2S,3S)-3-[(1-benzyloxycarbonylamino-cyclohexanecarbonyl)-amino]-4-oxo-azetidin-2-yl ester 
• 561039-31-4 (R)-1-{(S)-2-[(1-Benzyloxycarbonylamino-cyclohexanecarbonyl)-amino]-3-phenyl-propionyl}-pyrrolidine-2-carboxylic acid tert-butyl ester 
• 842120-71-2 [1-(benzyloxycarbonylamino)cyclohexyl]carbonyl-L-proline methyl ester 
• 940868-37-1 benzyl {1-[amino(hydroxyimino)methyl]cyclohexyl}carbamate 
• 519028-34-3 2-(1-amino-cyclohexyl)-5,6-dihydroxy-pyrimidine-4-carboxylic acid 4-fluoro-benzylamide 
• 842120-72-3 [1-(benzyloxycarbonylamino)cyclohexyl]carbonyl-L-proline 
• 842120-73-4 dibenzyl [1-(benzyloxycarbonylamino)cyclohexyl]carbonyl-L-prolyl-L-glutamate 
• 144876-65-3 1-Amino-cyclohexanecarboxylic acid 2-trimethylsilanyl-ethyl ester 
• 144876-60-8 2-(trimethylsilyl)ethyl-1-isocyanato-1-cyclohexane carboxylate 
• 144876-95-9 <10R-(10α,14β,17α)>-10-(1H-indol-3-ylmethyl)-8,11,16,19-tetraoxo-14-phenyl-7,9,12,15,18-pentaazaspiro<5,13>nonadecane-17-acetic acid 
• 144876-92-6 methyl <10R-(10α,14β,17α)>-10-(1H-indol-3-ylmethyl)-8,11,16,19-tetraoxo-14-phenyl-7,9,12,15,18-petaazaspiro<5,13>nonadecane-17-acetate 
• 144876-79-9 phenylmethyl -<2-<<3-(1H-indol-3-yl)-2-<(4-oxo-3-oxa-1-azaspiro<4.5>dec-1-en-2-yl)amino>-1-oxopropyl>amino>-1-phenylethyl>carbamate 

Relevant articles and documents

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

Embodiments of this invention provide compounds, compositions, methods, and uses for therapeutic diketopiperazines, including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat Pitt Hopkins Syndrome and symptoms thereof, as well a

The synthesis of α,α-disubstituted α-amino acids via ichikawa rearrangement

An approach to α,α-disubstituted α-amino acids is reported. The key step is allyl cyanate-to-isocyanate rearrangement. As demonstrated, the resultant allyl isocyanates can be directly trapped with various nucleophiles, for instance, alcohols, amines, and organometallic reagents, to provide a broad range of N-functionalized allylamines. The developed method has been successfully applied in the synthesis of two bioactive peptides: 2-aminoadamantane-2-carboxylic acid derived P2X7-evoked glutamate release inhibitor and 4-amino-tetrahydropyranyl-4-carboxylic acid derived dipeptide GSK-2793660, which is currently in clinical trials as cathepsin C inhibitor for the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis.

Foldamer-mediated remote stereocontrol: >1,60 asymmetric induction

An N-terminal L-α-methylvaline dimer induces complete conformational control over the screw sense of an otherwise achiral helical peptide foldamer formed from the achiral quaternary amino acids Aib and Ac6c. The persistent right-handed screw-sense preference of the helix enables remote reactive sites to fall under the influence of the terminal chiral residues, and permits diastereoselective reactions such as alkene hydrogenation or iminium ion addition to take place with 1,16-, 1,31-, 1,46- and even 1,61-asymmetric induction. Stereochemical information may be communicated in this way over distances of up to 4 nm. Reaction at a distance: By inducing a quantitative, persistent preference for right-handed helicity, chirality at one end of an otherwise achiral helical molecule is able to control the stereoselectivity of reactions at sites located up to 60 bonds away, shattering previous records for remote stereochemical control. Copyright